Barclays and ByteDance join LOT Network

Barclays and ByteDance join LOT Network

Barclays joins LOT Network and Open Invention Network Community Barclays takes action against attacks from patent trolls Barclays is the first major European headquartered bank to join LOT Network and Open Invention Network Community to oppose the abuse of...

Anaqua Successfully Completes SOC 2 Examination

Leading IP management solutions provider demonstrates strength of commitment to information and systems security BOSTON, January 26, 2021 – Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that it has...

Ropes & Gray and Novavax pursue a COVID-19 vaccine

Ropes & Gray’s life sciences practice played a critical role in helping longstanding client Novavax, Inc. pursue a COVID-19 vaccine; on January 28, Novavax announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a...

A guide to the most influential, innovative, and powerful figures and teams in the corporate patent industry.

Read more

More Copyright News

The Patent Power 50

The Patent Power 50 will highlight leading Corporate Patent In-house individuals and teams from around the world, across a multitude of sectors. Our goal is to recognize the game changers, movers, and shakers who are really making a difference to our industry. Being...

read more

Questel acquires RenewalsDesk

Questel announces the acquisition of RenewalsDesk, a UK-based company specializing in patent annuity services. RenewalsDesk was founded in 2013 by a patent owner who discovered high hidden fees with their former provider, with a mission to bring honesty and...

read more

Unwired Planet v Huawei FRAND judgment

The judgment by the UK Supreme Court in the dispute between Unwired Planet, Huawei et al, covering two appeals by cell phone manufacturers (implementers) of wireless technologies, is a landmark case in the area of Standard Essential Patents (“SEPs”) and FRAND...

read more

Patent types explained: utility, design, and plant

The canny entrepreneur should have a solid understanding of the importance of IP. Here, Josh Gerben, founder of Gerben Law Firm, PLLC, explains the three different types of patents available to inventors in the US, and outlines how to apply for them. A patent is a...

read more

Clarivate to combine with CPA Global

In a significant move, Clarivate has announced that it has signed a definitive agreement to combine with CPA Global. The transaction is expected to close in the fourth quarter of 2020. CPA Global currently provides IP management and technology solutions to more than...

read more

Anaqua launches dedicated law firm business unit

In a bid to address the diverse needs of today’s global law firms, IP management software company Anaqua has launched a new Anaqua Law Firms business unit and announced three senior hires. The move, says Anaqua, underscores the company’s commitment to the law firm...

read more

Movers and shakers – July 2020

Perhaps unsurprisingly, the past few weeks have seen a reduction in job appointments and other such announcements. There have, however, been a few important developments here and there. For starters, marking an exciting and significant moment, Johansson &...

read more

USPTO launches COVID-19 Response Resource Center

In the latest in a series of steps intended to bring calm to the US IP landscape in the face of coronavirus, the United States Patent and Trademark Office (USPTO) has launched a “COVID-19 Response Resource Center” to “provide stakeholders and other interested parties...

read more

Apple patents “synthetic group selfies”

In what, with hindsight, seems like an obvious innovation in our socially distanced, locked down age, California tech giant Apple has successfully applied for a US patent for “synthetic group selfies”. Apple’s patent, granted on 2 June by the USPTO, covers the...

read more

China Life Sciences collaboration for Rouse and Codex

International IP firm Rouse and Life Sciences services provider Codex have announced a collaboration that is intended to support life sciences companies accessing the Chinese market. The rapid spread of COVID-19 has intensified the global search for treatments,...

read more

“Eureka” for COVID-19 test inventor

The inventor of a ground-breaking COVID-19 test described his “eureka moment” when he realized he could adapt existing tech to create a rapid virus test. Professor Chris Toumazou is the co-founder of DnaNudge, which produces App technology that uses DNA and lifestyle...

read more

USPTO may prioritize COVID-19 applications

The United States Patent and Trademark Office (USPTO) has asked for comments on its proposal to fast-track patent applications relating to COVID-19 – a so-called Prioritized Examination Pilot Program (PEPP). In a statement released on its website, the USPTO says that...

read more

Renewed calls for a unified EU patent system

Despite, or maybe because of recent high-profile blows to the planned implementation of such a system, EU Internal Market Commissioner Thierry Breton has once again called upon Member States to move forward with a unified EU patent. Breton’s call comes at a time when...

read more

WHO wants a COVID patent pool?

The annual world health assembly, the forum through which the World Health Organization (WHO) is governed and an event which involves almost every country in the world, began (via videolink) on 18 May. At the top of the agenda is, of course, the current COVID-19...

read more

The effect of design space on patent grant and recognition for designs

Dr. Yongqiang Qi, Partner and Patent Attorney at Corner Stone, examines the latest judicial interpretation and what it means for design.

Incentivizing patents in the public interest: the case for combatting climate change and COVID-19

Pat Breslin, CEO of Breslin Consulting, explains the role for innovation to protect public health and welfare against widespread disease, environmental degradation, and natural disasters.

The uncharted path for patenting Artificial Intelligence in the US

Marc V. Richards and Scott Ilhwan Yoo, of Brinks Gilson & Lione, examine the state of patenting AI-related and AI-generated inventions and a path forward in view of the rejection of the DABUS patent applications.

A no-deal Brexit: Britain at risk of becoming a “third country”

Vanessa Bélec, Patent Attorney at Fenix Legal, discusses the impact Brexit will have on patent owners’ rights and why this is encouraging British companies to register their companies in Sweden.

An interview with Senior Vice President of IP at Genprex, Thomas Gallagher

Faye Waters, Editor of The Patent Lawyer, talks with Thomas Gallagher about his recent appointment as Genprex’s Senior Vice President and about his in-house counsel experiences.

A Nobel Prize, a Global Pandemic, and a Patent Dispute walk into a bar… stop me if you’ve heard this one before

Richard Gaugeler, Patent Attorney at Cedar White Bradley, explains how a Noble Prize, the Pandemic and a Patent Dispute are all inextricably linked to the CRISPR-Cas9 Technology.

Patent term adjustments due to delays in prosecution in Mexico

Victor Garrido, Head of Patents at Dumont, discusses the changes in Mexican FLPIP law and what the addition of supplementary certificates means for a patent’s protection period.ent Dispute are all inextricably linked to the CRISPR-Cas9 Technology.

Introduction to the Fourth Amendment to China’s Patent Law

Dr. Dan Zou, Patent Attorney at CCPIT, provides an overview of the changes coming into force in June 2021.

Determining joint inventorship: antibody paying attention?

Katherine M. Tassmer & Dr. Todd E. Garabedian, of Cantor Colburn LLP, discuss the tenets of joint inventorship under U.S. law with specific reference to the Dana-Farber decision.

Women in IP Leadership

Carlyn Burton: Partner, Osha Bergman Watanabe & Burton

Women in IP Leadership

Liz Cohen: Joint Managing Partner and IP specialist, Bristows LLP

Brazil: a discussion more current than ever on patent validity terms

Ana Paula Affonso Brito, Attorney at Law and Partner of Montaury Pimenta, Machado & Vieira de Mello, looks at the discussions around patents validity terms and the implications on the development of a COVID-19 vaccine
and innovation.

Growing patent damages – a look behind the headlines

Faye Waters, Editor of The Patent Lawyer Magazine, examines the recent cases that broke the high-water mark for patent damages awards and finds surprising commonalities.

Case study: infringement potential analysis in a complex and diversified industry

Philipp E. Hammans and Alexander Gangnus, of Dennemeyer Consulting GmbH, discuss a recent case in which their report aided their client to gain robust insights into his relative competitive and technological position
within the industry.

Inventiveness determination for inventions involving microorganisms

Peiyuan Zhang and Dongcheng Pang, of Beijing Sanyou, take suggestion from a recent judgement at China’s Supreme Court on the requirements for the inventiveness step.

Speaking of leaders and laggards of innovations

D.P.S Parmar, Special Counsel at LexOrbis, discusses the technicalities of improvement patents and modification patents with reference to blanket patenting and picket-fencing.

Medical patents, a country analysis: factors affecting patentability of medicine and primary health care

Lyudmila Lisovskaya, Patent and Chemical Specialist at Zuykov, details the difficulties surrounding the patentability of medicines, methods of prevention, diagnosis, and treatment of diseases around the world.

LOT Network: why the largest portfolio in the world reduces risk from Patent Assertion Entities

Ken Seddon, CEO of LOT Network, Nigel Swycher, CEO of Cipher, and Kent Richardson, Partner at Richardson Oliver Law Group, provide an overview into the impact PAE’s can have and how LOT Network can help.ion, diagnosis, and treatment of diseases around the world.

A careful balance

Whilst patents provide exclusionary rights, it is important for the Courts to find the right balance between patentees’ rights and the public interest when deciding whether to grant an injunction. Here, Rachel Mumby, Partner at Bristows, and Olivia Henry, Associate at Bristows explore some of the issues which come up in the life sciences sector, highlighting the commentary in the Evalve v Edwards Lifesciences case.

Sign up to our newsletter!

Subscribe to our newsletter to stay up-to-date with all the most pertinent patent stories and news

Would you like to advertise your company in The Patent Lawyer Magazine?

The Patent Lawyer Magazine offers your firm the exclusive opportunity of targeting some of the world’s biggest Patent organizations by bringing you a purely Patent focused magazine.

IP Knowledge Share
Trademark Lawyer Magazine
IP Knowledge Share
The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!